Skip to main content
Top
Published in: BMC Psychiatry 1/2005

Open Access 01-12-2005 | Case report

Two cases of "cannabis acute psychosis" following the administration of oral cannabis

Authors: Bernard Favrat, Annick Ménétrey, Marc Augsburger, Laura E Rothuizen, Monique Appenzeller, Thierry Buclin, Marie Pin, Patrice Mangin, Christian Giroud

Published in: BMC Psychiatry | Issue 1/2005

Login to get access

Abstract

Background

Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users.

Case presentations

We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation) following oral administration of cannabis. In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented.

Conclusion

While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur.
Appendix
Available only for authorised users
Literature
1.
go back to reference Witton J, Murray RM: Reefer madness revisited: cannabis and psychosis. Rev bras Psiquiatr. 2004, 26: 2-CrossRefPubMed Witton J, Murray RM: Reefer madness revisited: cannabis and psychosis. Rev bras Psiquiatr. 2004, 26: 2-CrossRefPubMed
2.
go back to reference Ramaekers JG, Berghaus G, Van Laar M, Drummer OH: Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004, 73: 109-119. 10.1016/j.drugalcdep.2003.10.008.CrossRefPubMed Ramaekers JG, Berghaus G, Van Laar M, Drummer OH: Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004, 73: 109-119. 10.1016/j.drugalcdep.2003.10.008.CrossRefPubMed
3.
go back to reference Chaudry JM, Moss HB, Bashir A, Suliman T: Cannabis psychosis following bhang ingestion. British J Addiction. 1991, 86: 1075-1081.CrossRef Chaudry JM, Moss HB, Bashir A, Suliman T: Cannabis psychosis following bhang ingestion. British J Addiction. 1991, 86: 1075-1081.CrossRef
4.
go back to reference Arseneault L, Cannon M, Witton J, Murray RM: Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004, 184: 110-117. 10.1192/bjp.184.2.110.CrossRefPubMed Arseneault L, Cannon M, Witton J, Murray RM: Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004, 184: 110-117. 10.1192/bjp.184.2.110.CrossRefPubMed
5.
go back to reference Thomas H: A community survey of adverse effects of cannabis use. Drug Alcohol Depend. 1996, 42: 201-207. 10.1016/S0376-8716(96)01277-X.CrossRefPubMed Thomas H: A community survey of adverse effects of cannabis use. Drug Alcohol Depend. 1996, 42: 201-207. 10.1016/S0376-8716(96)01277-X.CrossRefPubMed
7.
go back to reference Johns A: Psychiatric effect of cannabis. Br J Psychiatry. 2001, 178: 116-122. 10.1192/bjp.178.2.116.CrossRefPubMed Johns A: Psychiatric effect of cannabis. Br J Psychiatry. 2001, 178: 116-122. 10.1192/bjp.178.2.116.CrossRefPubMed
8.
go back to reference Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H: Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002, 156: 319-27. 10.1093/aje/kwf043.CrossRefPubMed Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H: Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002, 156: 319-27. 10.1093/aje/kwf043.CrossRefPubMed
9.
go back to reference Robson P: Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001, 178: 107-15. 10.1192/bjp.178.2.107.CrossRefPubMed Robson P: Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001, 178: 107-15. 10.1192/bjp.178.2.107.CrossRefPubMed
11.
go back to reference Ames F: A clinical and metabolic study of acute intoxication with cannabis sativa and its role in the model psychoses. J Ment Sci. 1958, 104: 972-99.PubMed Ames F: A clinical and metabolic study of acute intoxication with cannabis sativa and its role in the model psychoses. J Ment Sci. 1958, 104: 972-99.PubMed
12.
go back to reference Talbott JA, Teague JW: Marihuana psychosis: acute toxic psychosis associated with the use of cannabis derivatives. JAMA. 1969, 210: 299-302. 10.1001/jama.210.2.299.CrossRefPubMed Talbott JA, Teague JW: Marihuana psychosis: acute toxic psychosis associated with the use of cannabis derivatives. JAMA. 1969, 210: 299-302. 10.1001/jama.210.2.299.CrossRefPubMed
13.
14.
go back to reference Chopra GS, Smith JW: Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry. 1974, 30: 24-27.CrossRefPubMed Chopra GS, Smith JW: Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry. 1974, 30: 24-27.CrossRefPubMed
16.
go back to reference Emrich HM, Leweke FM, Schneider U: Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav. 1997, 56: 803-7. 10.1016/S0091-3057(96)00426-1.CrossRefPubMed Emrich HM, Leweke FM, Schneider U: Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav. 1997, 56: 803-7. 10.1016/S0091-3057(96)00426-1.CrossRefPubMed
17.
go back to reference Thornicroft G: Cannabis and psychosis: is there epidemiological evidence for association. Br J Psychiatry. 1990, 157: 25-33.CrossRefPubMed Thornicroft G: Cannabis and psychosis: is there epidemiological evidence for association. Br J Psychiatry. 1990, 157: 25-33.CrossRefPubMed
18.
go back to reference Gruber AJ, Pope HG: Cannabis psychotic disorder: does it exist?. Am J Addictions. 1994, 3: 72-83. Gruber AJ, Pope HG: Cannabis psychotic disorder: does it exist?. Am J Addictions. 1994, 3: 72-83.
19.
go back to reference Thacore VR, Shukla SRP: Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry. 1976, 33: 383-386.CrossRefPubMed Thacore VR, Shukla SRP: Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry. 1976, 33: 383-386.CrossRefPubMed
20.
go back to reference Rottamburg D, Robins AH, Ben-Arie O, Teggin A, Elk R: Cannabis-associated psychosis with hypomanic features. Lancet. 1982, 2: 1364-1366. 10.1016/S0140-6736(82)91270-3.CrossRef Rottamburg D, Robins AH, Ben-Arie O, Teggin A, Elk R: Cannabis-associated psychosis with hypomanic features. Lancet. 1982, 2: 1364-1366. 10.1016/S0140-6736(82)91270-3.CrossRef
21.
go back to reference Imade AGT, Ebie JC: A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand. 1991, 83: 134-136.CrossRefPubMed Imade AGT, Ebie JC: A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand. 1991, 83: 134-136.CrossRefPubMed
23.
go back to reference Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L: Pharmacokinetics and metabolism of delta-9-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev. 1986, 38: 21-43.PubMed Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L: Pharmacokinetics and metabolism of delta-9-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev. 1986, 38: 21-43.PubMed
24.
go back to reference Giroud C, Michaud K, Sporkert F, Eap C, Augsburger M, Cardinal P, Mangin P: A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluids and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry (HILIC-MS). J Anal Toxicol. 2004, 28: 464-474.CrossRefPubMed Giroud C, Michaud K, Sporkert F, Eap C, Augsburger M, Cardinal P, Mangin P: A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluids and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry (HILIC-MS). J Anal Toxicol. 2004, 28: 464-474.CrossRefPubMed
25.
go back to reference Leweke FM, Schneider U, Thies M, Munte TF, Emrich HM: Effects of synthetic D9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology. 1999, 142: 230-235. 10.1007/s002130050884.CrossRefPubMed Leweke FM, Schneider U, Thies M, Munte TF, Emrich HM: Effects of synthetic D9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology. 1999, 142: 230-235. 10.1007/s002130050884.CrossRefPubMed
26.
go back to reference D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH: The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004, 29: 1558-72. 10.1038/sj.npp.1300496.CrossRefPubMed D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH: The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004, 29: 1558-72. 10.1038/sj.npp.1300496.CrossRefPubMed
Metadata
Title
Two cases of "cannabis acute psychosis" following the administration of oral cannabis
Authors
Bernard Favrat
Annick Ménétrey
Marc Augsburger
Laura E Rothuizen
Monique Appenzeller
Thierry Buclin
Marie Pin
Patrice Mangin
Christian Giroud
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2005
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-5-17

Other articles of this Issue 1/2005

BMC Psychiatry 1/2005 Go to the issue